Stock Market Reviews

BLFS (BioLife Solutions, Inc.) News

Get the latest news, insights, and market updates on BLFS (BioLife Solutions, Inc.). Explore the news page 6 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Peli BioThermal Announces Acquisition to Expand Cold Chain Logistics Solutions and Advance Cryogenic Cell and Gene Therapy Transport
  Peli BioThermal, a global leader in temperature-controlled logistics solutions, today announced the acquisition of Evo from BioLife Solutions, further expanding its leading portfolio of products, services, and technology across the pharmaceutical value chain. The Evo portfolio includes cryogenic shippers and the evoIS® technology platform, designed to meet the rigorous demands of the rapidly growing Cell and Gene Therapy (C&GT) sector.
  Oct 7, 2025 - $BLFS
• BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary
  BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools for the cell and gene therapy ("CGT") market, announces the sale of SAVSU Cleo Technologies, LLC. (f/k/a SAVSU Technologies, Inc.) ("SAVSU"), its wholly owned cold chain logistics subsidiary, for $25.5 million (subject to certain adjustments) in cash to Peli BioThermal, a global leader in temperature-controlled logistics solutions.
  Oct 7, 2025 - $BLFS
• Discovering Bank First And 2 More Stocks That May Be Trading Below Their Estimated Value
  As the U.S. stock market navigates through the complexities of a government shutdown and fluctuating economic indicators, major indices like the Dow Jones and S&P 500 have shown resilience with recent gains. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.
  Oct 6, 2025 - $BLFS
• Strong week for BioLife Solutions (NASDAQ:BLFS) shareholders doesn't alleviate pain of five-year loss
  BioLife Solutions, Inc. ( NASDAQ:BLFS ) shareholders should be happy to see the share price up 14% in the last quarter...
  Oct 2, 2025 - $BLFS
• BioLife Solutions And 2 Other Stocks That May Be Trading Below Their Estimated Value
  As the U.S. stock market reaches new highs, driven by optimism surrounding potential interest rate cuts, investors are keenly observing opportunities that may arise from these favorable conditions. In such an environment, identifying stocks that appear to be undervalued can be particularly appealing, offering potential for growth as the broader market continues its upward trajectory.
  Sep 5, 2025 - $BLFS
• Does BioLife Solutions (BLFS) Have the Potential to Rally 25.6% as Wall Street Analysts Expect?
  The consensus price target hints at a 25.6% upside potential for BioLife Solutions (BLFS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
  Aug 29, 2025 - $BLFS
• Core Scientific, NewAmsterdam Pharma, and More Stocks See Action From Activist Investors
  13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.
  Aug 29, 2025 - $BLFS
• Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed
  Despite industry headwinds, Envista, BioLife Solutions, InfuSystems and MariMed are leveraging innovation and strategy for growth.
  Aug 15, 2025 - $BLFS